Engineers Gate Manager LP Buys Shares of 14,092 Tabula Rasa HealthCare Inc (TRHC)

Engineers Gate Manager LP bought a new position in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 14,092 shares of the company’s stock, valued at approximately $1,144,000. Engineers Gate Manager LP owned approximately 0.07% of Tabula Rasa HealthCare as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. increased its position in shares of Tabula Rasa HealthCare by 29.7% in the 2nd quarter. BlackRock Inc. now owns 2,119,507 shares of the company’s stock valued at $135,288,000 after purchasing an additional 484,979 shares during the last quarter. Jennison Associates LLC increased its position in shares of Tabula Rasa HealthCare by 29.5% in the 2nd quarter. Jennison Associates LLC now owns 757,846 shares of the company’s stock valued at $48,373,000 after purchasing an additional 172,693 shares during the last quarter. NN Investment Partners Holdings N.V. increased its position in shares of Tabula Rasa HealthCare by 45.2% in the 3rd quarter. NN Investment Partners Holdings N.V. now owns 669,800 shares of the company’s stock valued at $54,380,000 after purchasing an additional 208,604 shares during the last quarter. Braun Stacey Associates Inc. increased its position in shares of Tabula Rasa HealthCare by 199.0% in the 2nd quarter. Braun Stacey Associates Inc. now owns 301,089 shares of the company’s stock valued at $19,219,000 after purchasing an additional 200,394 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of Tabula Rasa HealthCare by 52.3% in the 2nd quarter. Northern Trust Corp now owns 227,503 shares of the company’s stock valued at $14,522,000 after purchasing an additional 78,112 shares during the last quarter. Institutional investors own 75.88% of the company’s stock.

TRHC has been the topic of a number of recent analyst reports. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research report on Tuesday. Citigroup increased their price objective on shares of Tabula Rasa HealthCare to $100.00 and gave the company a “buy” rating in a research report on Thursday, October 11th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research report on Saturday, August 11th. Robert W. Baird reissued a “buy” rating and issued a $70.00 price objective on shares of Tabula Rasa HealthCare in a research report on Wednesday, August 8th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $99.00 price objective on shares of Tabula Rasa HealthCare in a research report on Tuesday. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $81.60.

NASDAQ TRHC opened at $72.96 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.33 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.36 billion, a P/E ratio of -1,824.00, a P/E/G ratio of 5.08 and a beta of 2.58. Tabula Rasa HealthCare Inc has a 12 month low of $27.10 and a 12 month high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.07. The firm had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.53%. The company’s revenue was up 66.3% on a year-over-year basis. During the same period last year, the firm posted $0.08 EPS. On average, research analysts forecast that Tabula Rasa HealthCare Inc will post 0.53 EPS for the current fiscal year.

In related news, CEO Calvin H. Knowlton sold 8,000 shares of the stock in a transaction on Friday, September 7th. The shares were sold at an average price of $85.98, for a total value of $687,840.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold a total of 48,000 shares of company stock worth $3,722,960 over the last ninety days. Insiders own 14.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Engineers Gate Manager LP Buys Shares of 14,092 Tabula Rasa HealthCare Inc (TRHC)” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/11/10/engineers-gate-manager-lp-buys-shares-of-14092-tabula-rasa-healthcare-inc-trhc.html.

Tabula Rasa HealthCare Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Recommended Story: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply